The growing demand for controlled immunological investigation and therapeutic design has spurred significant improvements in recombinant cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently generated using multiple expression methods, including bacterial hosts, mammalian cell cultures, and vi